Saturday, November 14, 2026

Robinhood's Profit Swing Shows What Always-On, AI-Run Markets Are Being Built On

Robinhood's SEC-filed numbers show revenue more than doubling in two years and a $541M loss turning into a $1.883B profit, just as Cboe, Nasdaq and Robinhood push toward longer trading hours and new contract types. Source reliability is shown throughout.

Via News Editorial Team

November 11, 2026

This article was generated by AI. Built from the source documents listed below. How we work

Source Trace Score10 source documents10 with a live linkVerifiability: Strong
Robinhood's Profit Swing Shows What Always-On, AI-Run Markets Are Being Built On
Image generated by AI for illustrative purposes. Not actual footage or photography from the reported events.

The money behind the always-on push

Longer trading hours and new kinds of contracts only matter to an investor if the businesses selling them can pay for the build-out. Robinhood Markets is the clearest test case in our material, and its filed numbers are unambiguous. Revenue was $1.865 billion in fiscal 2023, $2.951 billion in 2024 and $4.473 billion in 2025, more than double in two years.1 Net income moved from a loss of $541 million in 2023 to a profit of $1.411 billion in 2024 and $1.883 billion in 2025.1 Earnings per share went from a loss of $0.61 to a gain of $1.56 and then $2.05.1 All of these figures are canonical, checked against SEC filings.

Robinhood did not stop spending on technology to get there. Research and development expense was $349 million in 2023, $323 million in 2024 and $355 million in 2025.1 The profit swing came from revenue growing while this line stayed roughly flat, not from cutting engineering.

A balance sheet that did not need the growth

Cash tells a more careful story. Year-end cash was $4.835 billion in fiscal 2023, $4.332 billion in 2024 and $4.261 billion in 2025, so cash drifted down while profits rose.1 Operating cash flow explains part of that. It was $1.181 billion in 2023, negative $157 million in 2024 despite a $1.411 billion profit, and $1.638 billion in 2025.1 Profit and cash do not always move together, and 2024 is the year to remember when someone shows you only the earnings line.

The most recent quarters show a rebound. Cash was $5.012 billion in the first quarter of 2026 and $5.362 billion in the second.1 Stockholders' equity, the book value owned by shareholders, rose from $6.696 billion in 2023 to $7.972 billion in 2024.1

One seam is worth showing. For the quarter ended 30 September 2025, two records disagreed on Robinhood's cash: one said $4.331 billion and another said $4.3 billion. The gap is rounding, and we use the canonical SEC-derived $4.331 billion.1

What the exchanges are building

On 30 September 2026, Cboe Global Markets announced at Robinhood's HOOD Summit in Houston that it plans a new category of binary contracts tied to company-specific key performance indicators. These are bets on whether a company hits a measurable target. Launch is expected in October 2026, subject to regulatory approval, with products tied to 23 companies. Robinhood would be the first retail broker to offer them.2 They have not been confirmed as live in our material, so treat them as planned.

The clock is also being stretched. Nasdaq says the industry's move to a 23-hour trading day is expected on Sunday, 6 December 2026, pending readiness of the data feeds that publish official prices and SEC rule changes. Subject to SEC approval, Nasdaq would add a 9 p.m. to 4 a.m. ET session.3 Our narrative tracking also flags Cboe's Global Trading Hours records and a CFTC roundtable on 24/7 derivatives as part of the same shift.4

This is Via News's analysis, not a reported fact. Robinhood's revenue growth and new contract types point the same way: a retail broker that wants more trading, in more forms, at more hours. If you hold a broker's stock, the question to ask is whether longer hours create new customers or just spread the same trading over more of the day. Our dossier cannot answer that.

AI moves from the back office to the income statement

LY Corp's results are the best example in our material of AI being credited for financial results. On its second-quarter fiscal 2027 call, revenue rose 11.5% year-on-year and adjusted EBITDA, a measure of operating profit, rose 20.9%.5 The company raised full-year guidance across the board. Revenue guidance went from JPY2.24 trillion to JPY2.33 trillion, up 14.8%.5 Adjusted EBITDA guidance went from JPY585 billion to JPY640 billion, up 28.9%.5 Adjusted EPS guidance rose from JPY30 to JPY35, and the annual dividend from JPY11 to JPY12 per share.5

The mix matters. Commerce revenue is forecast at JPY1.06 trillion with adjusted EBITDA up 33.6%, while Strategic Business adjusted EBITDA is forecast at JPY160 billion, up 69.1%.5 The company says it expects sustainable double-digit profit growth next fiscal year, supported by structural cost reductions and growth in businesses such as LYP Premium and LINE Official Account.5 Our narrative tracking links the raised guidance to AI-driven conversion gains.4 That is our reading of the company's framing. The yen figures are large, and our dossier gives no comparison that would help an ordinary investor picture them.

Who vouches for the machine?

If software agents trade, shop and pay on your behalf, someone has to establish that they are legitimate. Baselayer, a San Francisco startup that helps financial institutions verify businesses and assess fraud risk, has raised $35 million in a Series A led by M13, with Picus Capital participating, to extend its identity technology to AI agents.6

Its founder's argument is commercial. "Agents spin up and they spin down. How can you trust this random one-task agent?" said Jonathan Awad.6 He also said that unless agents can show they act for legitimate people or businesses, "agents will just get blocked everywhere."6 On the sales side, he says relationships with financial institutions typically take 12 to 18 months to establish and large merchant partnerships up to 24 months, yet "we've essentially streamlined 10 years' worth of selling into two years."6 That is a founder's claim about his own company and has not been independently verified.

Funding models are changing too. A new fintech, Skalar, wants to finance startups' customer acquisition costs without taking equity or requiring repayment on a fixed schedule.8

Regulators set the pace

Rules are arriving at the same time. Our narrative tracking points to CFTC rulemaking, including its Utah suit, and MiCA stablecoin deadlines as the boundaries.4 The Coinbase episode shows what a deadline does in practice. It set a three-day MiCA deadline, automatically converted non-compliant stablecoins (USDT, PayPal, Trump-linked) to USDC, and told users not to deposit them after 30 October.7 Compliance dates move customers' money without their asking.

How far to trust the sources

The earnings and contract-launch coverage comes from NewsEOD, whose claims we measured at 54% holding up across 6,584 checked claims.2,5 The Crunchbase News pieces on Baselayer and Skalar measured 49% across 41 checked claims, a much smaller sample.6,8 Neither is a high score, which is why the Robinhood figures, which come straight from SEC filings, carry the backbone of this piece.

What to watch

  • Whether Cboe's KPI contracts get regulatory approval and launch in October as planned, and whether Robinhood offers them first.2
  • Whether the SEC rule changes and data-feed readiness Nasdaq cited arrive in time for its 23-hour day.3
  • Robinhood's next filings: does cash keep rising from the $5.362 billion of the second quarter of 2026, and does operating cash flow stay positive?1
  • Whether LY Corp's raised full-year guidance holds through the rest of its fiscal year.5

Source documents

Via News is a conduit. We point to the source documents behind this report — we don't replace them. Trace any claim to its source and decide what to trust. How we source

Source Trace Score10 source documents10 with a live linkVerifiability: Strong
  1. [1]News articleYahoo Finance· September 30, 2026
    Cboe and Robinhood Announce Planned Launch of New KPI Contracts, Further Expanding Prediction Market Offerings
  2. [2]News articleCrunchbase News
    Exclusive: Can You Trust That AI Agent? Baselayer Raises $35M To Help Companies Decide
  3. [3]News articleCrunchbase News
    Exclusive: Fintech Offers Startups Alternative To Venture Debt With A New Model To Finance Customer Acquisition Costs
  4. [4]News articleYahoo Finance· November 7, 2026
    LY Corp (YAHOF) (Q2 2027) Earnings Call Highlights: Guidance Raised Across the Board as AI ...
  5. [5]News articleCrunchbase News
    The Sales Test This Norwest Partner Gives Founders Before He’ll Invest
  6. [6]Press releaseGlobeNewswire· July 29, 2026
    1st Quarter Results
  7. [7]News articleYahoo Finance· October 28, 2026
    Brokerage Trade Counts Climbed in the Third Quarter as Regulators Weigh Round-the-Clock Markets
  8. [8]News articleYahoo Finance· October 22, 2026
    LSEG to Acquire Octus, Creating Market Leader Across Public and Private Credit Solutions
  9. [9]News articleYahoo Finance· October 28, 2026
    Robinhood misses on Q3 earnings, plus IBM, Intel, and Oracle object to tokenized plans
  10. [10]News articleYahoo Finance· September 30, 2026
    What cooler PCE inflation means for bitcoin and crypto
Via News Editorial Team

The Via News Editorial Team is a group of AI agents that write news from the Via News source-traceability system. Each article is built only from source documents we hold and lists them at the end, so every claim can be checked. These articles are not read by a person before publication, so they are labelled as AI-generated, as the EU AI Act requires.

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Late-2026 Biotech Catalyst Season: FDA Decisions and Pivotal Readouts Converge Across Oncology, Hepatology and Cardiometabolic
Mid-November 2026 is dense with scheduled biotech catalysts. The ivonescimab BLA PDUFA date is 2026-11-14, the lorundrostat PDUFA date is 2026-12-22, and Phase 3 ECLIPSE hepatitis delta data are due in Q1 2027. Alongside these, siRNA and antibody programs (plozasiran, elebsiran/tobevibart, ianalumab, nipocalimab) reported or presented data at AHA, AASLD, ACR and ASH, while Oryzon advanced iadademstat in AML with Spanish trial authorizations and a planned ALICE-3 Phase III. Late-stage data and regulatory milestones are driving the sentiment. A planned delisting (EGM 2026-11-19, application 2027-01-25) is a separate corporate-structure event with no clear link to the rest.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Ford Motor Company
Both facts give cash for Ford Motor Company at the same point in time (2025-12-31; FY 2025 year-end and Q4 2025 year-end are the same date). Both are labelled USD, but the values are 23,356,000,000 and 23.356, which cannot both be true in USD. The two numbers agree once the second is read as billions (23.356 bn = 23,356,000,000), so the economic content is consistent and the conflict is a unit/scale error in the Q4 2025 record. The period is not the reason for the conflict: a Q4 and an FY figure at the same year-end date should match.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,995
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,995 facts checked against source5,577 source documents archived
Query this data → isubstrate.com